• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Transnasal humidified rapid insufflation ventilatory exchange for oxygenation of children during apnoea: a prospective randomised controlled trial.
 

Transnasal humidified rapid insufflation ventilatory exchange for oxygenation of children during apnoea: a prospective randomised controlled trial.

Options
  • Details
BORIS DOI
10.7892/boris.112644
Date of Publication
March 2018
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Author
Riva, Thomas
Universitätsklinik für Anästhesiologie und Schmerztherapie
Pedersen, Tina Heidi
Universitätsklinik für Anästhesiologie und Schmerztherapie
Seiler, Stefan Jürg
Universitätsklinik für Anästhesiologie und Schmerztherapie
Kasper, Nina Elisabeth
Universitätsklinik für Anästhesiologie und Schmerztherapie
Theiler, Lorenz
Universitätsklinik für Anästhesiologie und Schmerztherapie
Greif, Robertorcid-logo
Universitätsklinik für Anästhesiologie und Schmerztherapie
Kleine-Brüggeney, Maren
Universitätsklinik für Anästhesiologie und Schmerztherapie
Subject(s)

600 - Technology::610...

Series
British journal of anaesthesia
ISSN or ISBN (if monograph)
0007-0912
Publisher
Elsevier
Language
English
Publisher DOI
10.1016/j.bja.2017.12.017
PubMed ID
29452816
Uncontrolled Keywords

THRIVE apnoeic oxygen...

Description
BACKGROUND

Transnasal humidified rapid insufflation ventilatory exchange (THRIVE) comprises the administration of heated, humidified, and blended air/oxygen mixtures via nasal cannula at rates of ≥2 litres kg min. The aim of this randomized controlled study was to evaluate the length of the safe apnoea time using THRIVE with two different oxygen concentrations (100% vs 30% oxygen) compared with standard low-flow 100% oxygen administration.

METHODS

Sixty patients, aged 1-6 yr, weighing 10-20 kg, undergoing general anaesthesia for elective surgery, were randomly allocated to receive one of the following oxygen administration methods during apnoea: 1) low-flow 100% oxygen at 0.2 litres kg min; 2) THRIVE 100% oxygen at 2 litres kg min; and 3) THRIVE 30% oxygen at 2 litres kg min. Primary outcome was time to desaturation to 95%. Termination criteria included SpOdecreased to 95%, transcutaneous COincreased to 65 mmHg, or apnoea time of 10 min.

RESULTS

The median (interquartile range) [range] apnoea time was 6.9 (5.7-7.8) [2.8-10.0] min for low-flow 100% oxygen, 7.6 (6.2-9.1) [5.2-10.0] min for THRIVE 100% oxygen, and 3.0 (2.4-3.7) [0.2-5.3] min for THRIVE 30% oxygen. No significant difference was detected between apnoea times with low-flow and THRIVE 100% oxygen administration (P=0.15). THRIVE with 30% oxygen demonstrated significantly shorter apnoea times (P<0.001) than both 100% oxygen modalities. The overall rate of transcutaneous COincrease was 0.57 (0.49-0.63) [0.29-8.92] kPa minwithout differences between the 3 groups (P=0.25).

CONCLUSIONS

High-flow 100% oxygen (2 litres kg min) administered via nasal cannulas did not extend the safe apnoea time for children weighing 10-20 kg compared with low-flow nasal cannula oxygen (0.2 litres kg min). No ventilatory effect was observed with THRIVE at 2.0 litres kg min.

CLINICAL TRIAL REGISTRATION

NCT02979067.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/159227
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
PIIS0007091217542063.pdftextAdobe PDF503.44 KBpublisherpublished restricted
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo